In this episode of Indiana 250 Off the Record, host Nate Feltman talks with Dr. Richard DiMarchi, Indiana University Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences.  A distinguished scientist and entrepreneur,  Dr. DiMarchi’s groundbreaking diabetes research while at Eli Lilly and Company laid the foundation for the new class of obesity drugs that today are transforming lives worldwide.  Since his retirement from Lilly, Dr. DiMarchi has co-founded six biotech companies, including MBX Biosciences which recently went public.  With more than 100 U.S. patents and numerous accolades, including an induction into the National Inventors Hall of Fame, Dr. DiMarchi shares insights into his career journey, the impact of mentorship, the future of biotechnology, and the essential role of diversity and innovation in advancing medical research.